Evidence map

ReviewClinical pharmacokinetics2018

Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor.

Sreeneeranj Kasichayanula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

72 papers cite itlatest 60 shown

2018
2019
2021
2022
2023
2024
2025
2026
this papertrialcites it

13 trials

Full record →Abstract, authors, funding and every citing paper · PMID 29353350